A growing body of evidence indicates that MMP14 is up-regulated in diverse aggressive tumor and stromal cells, and thus, MMP14 originating from microglia or glioma cells is emerging as a potential interventional target for glioma therapy [15]. Here, MMP14 is linked to central nervous system cancer.